Search Results

There are 1921 results for: content related to: Editorial: New drugs for Alzheimer's disease in Japan

  1. Galantamine for Alzheimer's disease and mild cognitive impairment

    Intervention Review

    The Cochrane Library

    Clement Loy and Lon Schneider

    Published Online : 25 JAN 2006, DOI: 10.1002/14651858.CD001747.pub3

  2. Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease

    The Journal of Clinical Pharmacology

    Volume 46, Issue S1, July 2006, Pages: 17S–26S, Dr George T. Grossberg, Dr Keith R. Edwards and Dr Qinying Zhao

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006288735

  3. Development of a novel high-concentration galantamine formulation suitable for intranasal delivery

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 8, August 2005, Pages: 1736–1746, Alexis Kays Leonard, Anthony P. Sileno, Conor MacEvilly, Charles A. Foerder, Steven C. Quay and Henry R. Costantino

    Article first published online : 28 JUN 2005, DOI: 10.1002/jps.20389

  4. Galantamine for vascular cognitive impairment

    Intervention Review

    The Cochrane Library

    Jacqueline Birks and David Craig

    Published Online : 25 JAN 2006, DOI: 10.1002/14651858.CD004746.pub2

  5. Steady-State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 519–528, Dr Caiping Yao, Dr Arash Raoufinia, Dr Michael Gold, Dr Jeffrey S. Nye, Dr Steven Ramael, Mr Mukund Padmanabhan, Dr Yolande Walschap, Dr Tom Verhaeghe and Dr Qinying Zhao

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005274551

  6. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons

    European Journal of Neuroscience

    Volume 29, Issue 3, February 2009, Pages: 455–464, Joana B. Melo, Carla Sousa, Pedro Garção, Catarina R. Oliveira and Paula Agostinho

    Article first published online : 2 FEB 2009, DOI: 10.1111/j.1460-9568.2009.06612.x

  7. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease

    Psychogeriatrics

    Mizuki Oka, Shutaro Nakaaki, Atsushi Negi, Jun Miyata, Atsuo Nakagawa, Nobutsugu Hirono and Masaru Mimura

    Article first published online : 26 JUN 2015, DOI: 10.1111/psyg.12132

  8. You have free access to this content
    Effect of galantamine on the human α7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity

    British Journal of Pharmacology

    Volume 145, Issue 5, July 2005, Pages: 672–678, Laura Texidó, Esteve Ros, Mireia Martín-Satué, Susana López, Jordi Aleu, Jordi Marsal and Carles Solsona

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706221

  9. You have free access to this content
    Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells

    British Journal of Pharmacology

    Volume 145, Issue 8, August 2005, Pages: 1084–1092, Jacques Barik, Federico Dajas-Bailador and Susan Wonnacott

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706278

  10. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong

    International Journal of Clinical Practice

    Volume 61, Issue 3, March 2007, Pages: 403–410, L. W. Chu, P. Y. Yik, W. Mok and C. P. Chung

    Article first published online : 14 FEB 2007, DOI: 10.1111/j.1742-1241.2007.01284.x

  11. Galantamine Maintains Ability to Perform Activities of Daily Living in Patients with Alzheimer's Disease

    Journal of the American Geriatrics Society

    Volume 52, Issue 7, July 2004, Pages: 1070–1076, Douglas Galasko, Paul R. Kershaw, Lon Schneider, Young Zhu and Pierre N. Tariot

    Article first published online : 15 JUN 2004, DOI: 10.1111/j.1532-5415.2004.52303.x

  12. Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells

    Journal of Pineal Research

    Volume 49, Issue 2, September 2010, Pages: 141–148, Alejandro Romero, Javier Egea, Antonio G. García and Manuela G. López

    Article first published online : 1 JUN 2010, DOI: 10.1111/j.1600-079X.2010.00778.x

  13. Mild Cognitive Impairment

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt079

  14. You have free access to this content
    Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice

    British Journal of Pharmacology

    Volume 156, Issue 1, January 2009, Pages: 173–180, K Yano, K Koda, Y Ago, H Kobayashi, T Kawasaki, K Takuma and T Matsuda

    Article first published online : 24 DEC 2008, DOI: 10.1111/j.1476-5381.2008.00037.x

  15. Analyses of mortality risk in patients with dementia treated with galantamine

    Acta Neurologica Scandinavica

    Volume 119, Issue 1, January 2009, Pages: 22–31, H. H. Feldman, T. Pirttila, J. F. Dartigues, B. Everitt, B. Van Baelen, H. R. Brashear, J. A. Berlin, W. P. Battisti and S. Kavanagh

    Article first published online : 1 JUN 2008, DOI: 10.1111/j.1600-0404.2008.01047.x

  16. Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease

    ELECTROPHORESIS

    Volume 30, Issue 4, February 2009, Pages: 644–653, Ya-Hui Hsieh, Yuan-Han Yang, Hsin-Hua Yeh, Ping-Chih Lin and Su-Hwei Chen

    Article first published online : 23 JAN 2009, DOI: 10.1002/elps.200800559

  17. Galantamine Population Pharmacokinetics in Patients with Alzheimer's Disease: Modeling and Simulations

    The Journal of Clinical Pharmacology

    Volume 43, Issue 5, May 2003, Pages: 514–523, Vladimir Piotrovsky, Achiel Van Peer, Nancy Van Osselaer, Martin Armstrong and Jeroen Aerssens

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270003251853

  18. Non-cognitive benefits of galantamine (Reminyl®) treatment in vascular dementia

    Acta Neurologica Scandinavica

    Volume 106, Issue s178, December 2002, Pages: 19–24, A. Kurz

    Article first published online : 18 DEC 2002, DOI: 10.1034/j.1600-0404.106.s178.5.x

  19. A Novel Treatment for Patients with Alzheimer's Disease and with Vascular Dementia

    Annals of the New York Academy of Sciences

    Volume 977, Issue 1, November 2002, Pages: 476–481, ALEXANDER KURZ

    Article first published online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb04853.x

  20. Alzheimer's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt063